https://biotechmorning.com 2026-03-03T18:46:40.702Z daily 1 https://biotechmorning.com/issues 2026-03-03T18:46:40.702Z daily 0.8 https://biotechmorning.com/news 2026-03-03T18:46:40.702Z daily 0.9 https://biotechmorning.com/news/ql-biopharm-series-c-monthly-glp1 2026-03-03T18:13:20.103Z never 0.8 https://biotechmorning.com/news/mash-claims-another-victim-boehringer-ose 2026-03-03T18:12:41.586Z never 0.8 https://biotechmorning.com/news/abbvie-skyrizi-crohns-hard-to-treat 2026-03-03T18:12:30.980Z never 0.8 https://biotechmorning.com/news/fda-sham-surgery-huntington-gene-therapy 2026-03-03T18:11:48.756Z never 0.8 https://biotechmorning.com/news/crispr-armed-phage-therapy-first-safety-trial 2026-03-03T18:10:56.696Z never 0.8 https://biotechmorning.com/news/bms-sotyktu-psoriatic-arthritis-fda-decision 2026-03-03T18:09:53.791Z never 0.8 https://biotechmorning.com/news/biohaven-reverses-rd-cuts-molecular-degraders 2026-03-03T18:09:09.544Z never 0.8 https://biotechmorning.com/news/theravance-bet-everything-one-drug-lost 2026-03-03T18:08:20.179Z never 0.8 https://biotechmorning.com/news/oncolytic-virus-colorectal-cancer-trial 2026-03-02T16:30:46.788Z never 0.8 https://biotechmorning.com/news/lynk-zemprocitinib-eczema-phase-3-results 2026-03-02T16:30:00.796Z never 0.8 https://biotechmorning.com/news/generate-biomedicines-ipo-face-plant 2026-03-02T16:29:18.004Z never 0.8 https://biotechmorning.com/news/roche-fenebrutinib-ms-phase-3-sweep 2026-03-02T16:28:30.163Z never 0.8 https://biotechmorning.com/news/matricelf-innovation-award-spinal-cord-injury 2026-03-02T16:27:36.030Z never 0.8 https://biotechmorning.com/news/septerna-sep-631-mrgprx2-urticaria-phase-1 2026-03-02T16:26:45.795Z never 0.8 https://biotechmorning.com/news/merck-keytruda-patent-cliff-reorganization 2026-03-02T00:01:25.449Z never 0.8 https://biotechmorning.com/news/biomarin-roctavian-gene-therapy-withdrawal 2026-03-02T00:00:33.111Z never 0.8 https://biotechmorning.com/news/viruses-found-weak-spot-superbugs-antibiotic-target 2026-03-01T23:59:46.542Z never 0.8 https://biotechmorning.com/news/rna-nanostars-programmable-organelles-bacteria 2026-03-01T23:59:03.102Z never 0.8 https://biotechmorning.com/news/slate-medicines-pacap-migraine-launch 2026-03-01T23:58:20.320Z never 0.8 https://biotechmorning.com/news/dupixent-ninth-fda-approval-afrs 2026-03-01T23:57:37.691Z never 0.8 https://biotechmorning.com/news/bms-china-adc-breast-cancer-phase-3-results 2026-03-01T23:56:48.969Z never 0.8 https://biotechmorning.com/news/senate-hearing-fda-rare-disease-roadblock 2026-02-27T21:54:17.246Z never 0.8 https://biotechmorning.com/news/psychedelics-without-the-trip 2026-02-27T21:24:52.656Z never 0.8 https://biotechmorning.com/news/abbvie-650m-remegen-bispecific-antibody 2026-02-27T21:24:49.146Z never 0.8 https://biotechmorning.com/news/novo-triple-g-obesity-drug-results 2026-02-27T21:24:43.366Z never 0.8 https://biotechmorning.com/news/885m-bet-adc-linker-technology-earendil-wuxi-xdc 2026-02-27T21:15:52.614Z never 0.8 https://biotechmorning.com/news/gilead-arcellx-7-8-billion-car-t-deal 2026-02-27T21:15:40.552Z never 0.8 https://biotechmorning.com/news/atrium-therapeutics-avidity-spinoff-270m 2026-02-27T21:15:37.521Z never 0.8 https://biotechmorning.com/news/sarepta-ceo-doug-ingram-retirement 2026-02-26T21:18:00.547Z never 0.8 https://biotechmorning.com/news/gsk-950m-35pharma-pulmonary-hypertension 2026-02-26T21:18:00.261Z never 0.8 https://biotechmorning.com/news/viatris-layoffs-biotech-2026-wave 2026-02-26T21:17:48.932Z never 0.8 https://biotechmorning.com/news/bms-adc-tnbc-phase-3-win 2026-02-26T21:17:45.274Z never 0.8 https://biotechmorning.com/news/novo-nordisk-vivtex-oral-obesity-pill-deal 2026-02-26T21:17:44.321Z never 0.8 https://biotechmorning.com/news/asahi-kasei-920m-aicuris-antiviral-acquisition 2026-02-26T21:17:43.772Z never 0.8 https://biotechmorning.com/news/boehringer-sitryx-500m-oral-autoimmune-deal 2026-02-26T21:17:43.438Z never 0.8 https://biotechmorning.com/news/accent-dhx9-inhibitor-clinical-hold-safety 2026-02-26T21:17:40.934Z never 0.8 https://biotechmorning.com/news/novo-ubt251-weight-loss-competitive-gap 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/fda-approves-smartphone-app-migraine-treatment 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/fda-one-patient-approval-plausible-mechanism 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/til-therapy-sarcoma-lifileucel-iovance 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/masked-t-cell-engager-astellas-vir-deal 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/130m-bet-migraine-patients-nobody-can-help 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/250-patients-changed-fda-playbook 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/zero-treatments-friedreichs-ataxia-larimar-breakthrough 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/fda-gene-therapy-startups-skip-gmp-phase2 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/protara-tara-002-bladder-cancer-response-rate-durability-collapse 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/gsk-250m-bora-pharmaceuticals-north-america-supply-chain 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/moderna-rare-disease-garage-sale 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/nih-funding-cuts-wrecking-ball-clinical-trials 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/novo-nordisk-cagrisema-loses-head-to-head-zepbound 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/rare-disease-biotech-hunger-problem 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/fortress-biotech-205m-priority-review-voucher-no-drug-sales 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/moonlake-90-percent-crash-fifth-positive-indication 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/ultragenyx-dtx401-gene-therapy-glycogen-storage-disease 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/fda-approval-skipped-phase-3-vanda-bysanti 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/biomarin-rival-benched-three-months 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/pfizer-monthly-weight-loss-shot-pf-3944 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/sanofi-fires-ceo-hudson-garijo-replacement 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/lilly-repertoire-immune-tolerance-deal 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/gossamer-bio-seralutinib-missed-endpoint-fda-filing 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/gilead-arcellx-7-8b-car-t-acquisition 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/india-30-billion-generic-drug-machine 2026-02-22T12:00:00.000Z never 0.8 https://biotechmorning.com/news/axsome-therapeutics-9b-market-cap-16b-cns-portfolio 2026-02-22T12:00:00.000Z never 0.8 https://biotechmorning.com/news/oxygen-gel-every-treated-mouse-survived 2026-02-22T12:00:00.000Z never 0.8 https://biotechmorning.com/news/novartis-nkg2d-qeq278-zero-responses-solid-tumors 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/galleri-blood-test-found-cancer-stock-tanked 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/tremfya-ulcerative-colitis-three-year-remission 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/crohns-pill-works-before-biologic-wakes-up 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/recursion-cfo-stock-sale-earnings 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/one-brain-tumor-freezes-two-gene-therapies 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/daiichi-sankyo-poached-novartis-drug-approval-machine 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/ionis-one-patient-alzheimers-down-syndrome-trial 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/scotus-killed-ieepa-tariffs-pharma-not-off-hook 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/revlimid-successor-iberdomide-fda-priority-review 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/roche-giredestrant-breast-cancer-pill-secret-weapon 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/virus-kills-prostate-cancer-100m-backer 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/issues/2026-03-03 2026-03-03T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-01 2026-03-01T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-02-27 2026-02-27T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-02-26 2026-02-26T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-02-25 2026-02-25T14:00:48.752Z never 0.7 https://biotechmorning.com/issues/2026-02-24 2026-02-24T14:00:20.018Z never 0.7 https://biotechmorning.com/issues/2026-02-23 2026-02-23T14:00:17.082Z never 0.7 https://biotechmorning.com/issues/2026-02-22 2026-02-22T14:00:24.908Z never 0.7 https://biotechmorning.com/issues/2026-02-21 2026-02-21T14:00:24.872Z never 0.7